Limitations in Balloon Dimensions Affect the Interpretation of REBOA Findings
-
By
-
Habib Frost
-
Anette Kristiansen
-
August 12, 2026
Clinical Report: Limitations in Balloon Dimensions Affect REBOA Findings
Background
Resuscitative endovascular balloon occlusion of the aorta (REBOA) is a technique aimed at optimizing blood flow during cardiac arrest. Understanding the limitations of balloon size is crucial, as inadequate occlusion may compromise the intervention's effectiveness. The findings from the REBOARREST trial highlight the need for careful consideration of device specifications in emergency settings.
Data Highlights
No numerical data provided in the source material.
Key Findings
- The REBOA Medical 20 mm balloon was used in the trial, which may lead to underinflation of the aorta.
- Median age of participants was 68 years, with a significant difference between aortic diameter and balloon size.
- Median time from cardiac arrest to balloon inflation was 47 minutes, exceeding the recommended low-flow time of 40 minutes.
- The study found no improvement in sustained return of spontaneous circulation with REBOA compared to advanced life support alone.
- 21 patients were excluded post-randomization, potentially affecting study demographics and outcomes.
Clinical Implications
Clinicians should be aware of the limitations associated with balloon size in REBOA procedures, particularly in the context of cardiac arrest.
Conclusion
The limitations identified in the REBOA trial emphasize the importance of device specifications and timely intervention.
Related Resources & Content
- European Resuscitation Council Guidelines 2025 Adult Advanced Life Support
- Prehospital resuscitative endovascular balloon occlusion of the aorta in non-traumatic out-of-hospital cardiac arrest (REBOARREST): an international, multicentre, open label, pragmatic, randomised, controlled trial - PMC
- Obesity Surgery — Is Endoscopic Intervention Essential for the Placement of Intragastric Balloons?
- Obesity Surgery — Response to the Editorial Regarding the Study: "Effectiveness of Initial Intragastric Balloon for Weight Reduction: A Systematic Review and Meta-Analysis of Randomized Trials
- Pediatric Cardiology — Comparative Efficacy of Drug-Eluting Balloons and Standard Balloon Angioplasty in Treating Peripheral Pulmonary Artery Stenosis in Pediatric Patients
- Basic Research in Cardiology — Effects of Repeated Balloon Inflation During Primary Percutaneous Coronary Intervention on Infarct Size and Long-Term Outcomes in ST-Segment Elevation Myocardial Infarction: Insights from Real-World Postconditioning
- European Resuscitation Council Guidelines 2025 Adult Advanced Life Support
- Prehospital resuscitative endovascular balloon occlusion of the aorta in non-traumatic out-of-hospital cardiac arrest (REBOARREST): an international, multicentre, open label, pragmatic, randomised, controlled trial - PMC
- Emergency department initiated resuscitative endovascular balloon occlusion of the aorta (REBOA) for out‐of‐hospital cardiac arrest is feasible and associated with improvements in end‐tidal carbon dioxide - ScienceDirect
Based on findings from:
Insufficient balloon size limits the interpretation of REBOARREST
Habib Frost, Anette Kristiansen. Critical Care, 2026.
https://link.springer.com/article/10.1186/s13054-026-06254-9
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.